MR1 & B2M

MR1 & B2M 製品リスト

  • 属性

    Protein (1)

  • 製品ライブラリ

    オンライン (1)

  • Human (1)

  • タグ

    His Tag & Avi Tag (1)

  • マーカー

    Biotin-labeled (1)

製品番号発現システム製品説明タンパク質の構造純度特性
MRM-H82W5
Human
HEK293
Biotinylated Human MR1&B2M Complex Protein (MALS verified)
総数量1
  • 1

MR1 & B2Mバックグランド

MR1 is also knwon as MHC class I-related gene protein. Antigen-presenting molecule specialized in displaying microbial pyrimidine-based metabolites to alpha-beta T cell receptors (TCR) on innate-type mucosal-associated invariant T (MAIT) cells. In complex with B2M preferentially presents riboflavin-derived metabolites to semi-invariant TRAV1-2 TCRs on MAIT cells, guiding immune surveillance of the microbial metabolome at mucosal epithelial barriers. Signature pyrimidine-based microbial antigens are generated via non-enzymatic condensation of metabolite intermediates of the riboflavin pathway with by-products arising from other metabolic pathways such as glycolysis. Typical potent antigenic metabolites are 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU) and 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU), products of condensation of 5-amino-6-D-ribityaminouracil (5-A-RU) with glyoxal or methylglyoxal by-products, respectively.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
NidanilimabCAN-04Phase 2 ClinicalLund University FoundationSolid tumours; Biliary Tract Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Melanoma
詳細
CCTx-001CCTx-001Phase 2 ClinicalAdvesya SASLeukemia, Myeloid, Acute
詳細
SAR-445399SAR-445399Phase 1 ClinicalSanofiInflammation
詳細
GSK3903371GSK3903371ClinicalGlaxosmithkline PlcNeoplasms
詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8